Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind, placebo-controlled, phase I/II clinical trial.

Tian Xiao ZhaoMichalis KostapanosCharmaine GriffithsEmma L ArbonAnnette HubschFotini KaloyirouJoanna HelmyStephen P HooleJames H F RuddGraham WoodKeith BurlingSimon BondJoseph CheriyanZiad Mallat

Published in: BMJ open (2018)

NCT03113773; Pre-results.

Keyphrases

double blind
placebo controlled
clinical trial
low dose
phase ii
study protocol
phase iii
acute coronary syndrome
open label
randomized controlled trial
phase ii study
pulmonary hypertension
squamous cell carcinoma
high dose
antiplatelet therapy
rectal cancer